Loar Holdings Inc (LOAR) Q3 2026 Earnings Call Highlights: Record Sales, 17th Straight
Loar Holdings Inc (LOAR) reported Q3 2026 earnings with record sales but lower net income due to higher expenses. CEO Dirkson Charles highlighted a strong backlog and new business wins, driving low double-digit growth expectations for 2027. The company anticipates flat to 2% available seat miles growth in 2027. M&A activity remains unpredictable. Analysts questioned growth drivers, margin improvements, and supply chain impacts.
How this was made
The 30-second read
Why it matters
The earnings call delivers fresh guidance that sets expectations for the next fiscal year, influencing investor sentiment and short‑term price action.
Market read
The new guidance may temper enthusiasm for Loar, leading to modest price movement; sector peers could be impacted by comparable demand trends.
What to watch
Backlog strength and book‑to‑bill above 1.1 could translate into higher revenue if conversion rates improve.
Background
Loar Holdings reported Q3 2026 results, highlighting a decline in net and adjusted income and providing 2027 outlook on ASM growth, EBITDA margin expansion, and M&A activity.
Ticker impact
Q3 2026 earnings call disclosed lower net income, adjusted income decline and modest 2027 guidance on ASM and EBITDA margin.
likely slight downside as investors weigh weaker income and modest growth outlook
The earnings call provides the first public guidance for 2027; the numbers are modest and below prior expectations, which typically leads to a modest sell pressure.
Market effects
Aerospace & defense suppliers may see limited upside as Loar signals choppy defense sales and modest airline capacity growth.
U.S. aerospace sector could experience slight pressure in the near term.
Limited; primarily affects niche aerospace component market.
Counterpoint
If Loar can accelerate new‑business wins faster than indicated, the guidance may be overly conservative, offering upside potential.
Key entities
- CompanyLoar Holdings Inc
Aerospace component manufacturer reporting Q3 2026 earnings and 2027 guidance.
